{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:16:25Z","timestamp":1787508985972,"version":"build-2736575974"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>Anticoagulation and antiplatelet therapies are increasingly used in liver transplant (LT) candidates and recipients due to cardiovascular comorbidities, portal vein thrombosis, or to manage posttransplant complications. The implementation of the new direct-acting oral anticoagulants and the recently developed antiplatelet drugs is a great challenge for transplant teams worldwide, as their activity must be monitored and their complications managed, in the absence of robust scientific evidence. In this changing and clinically heterogeneous scenario, the Spanish Society of Liver Transplantation and the Spanish Society of Thrombosis and Haemostasis aimed to achieve consensus regarding the indications, drugs, dosing, and timing of anticoagulation and antiplatelet therapies initiated from the inclusion of the patient on the waiting list to post-LT surveillance. A multidisciplinary group of experts composed by transplant hepatologists, surgeons, hematologists, transplant-specialized anesthesiologists, and intensivists performed a comprehensive review of the literature and identified 21 clinically relevant questions using the patient-intervention-comparison-outcome format. A preliminary list of recommendations was drafted and further validated using a modified Delphi approach by a panel of 24 transplant delegates, each representing a LT institution in Spain. The present consensus statement contains the key recommendations together with the core supporting scientific evidence, which will provide guidance for improved and more homogeneous clinical decision making.<\/jats:p>","DOI":"10.1097\/tp.0000000000004014","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T15:03:20Z","timestamp":1641740600000},"page":"1123-1131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation"],"prefix":"10.1097","volume":"106","author":[{"given":"Eva","family":"Montalv\u00e1","sequence":"first","affiliation":[{"name":"Department of HPB Surgery and Transplantation, La Fe University Hospital and University of Valencia, Instituto de Investigaci\u00f3n Sanitaria de La Fe, Valencia, Spain."},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodr\u00edguez-Per\u00e1lvarez","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Madrid, Spain."},{"name":"Department of Hepatology and Liver Transplantation, Reina Sof\u00eda University Hospital, IMIBIC, University of C\u00f3rdoba, C\u00f3rdoba, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Blasi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Hospital Cl\u00ednic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Bonanad","sequence":"additional","affiliation":[{"name":"Unidad de Hemostasia y Trombosis, Servicio de Hematolog\u00eda, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gav\u00edn","sequence":"additional","affiliation":[{"name":"Departamento de Hematolog\u00eda y Hemoterapia, Hospital Cl\u00ednico Universitario Lozano Blesa, Zaragoza, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Hierro","sequence":"additional","affiliation":[{"name":"Department of Liver Transplantation, Hospital Universitario La Paz, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Llad\u00f3","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit, Department of Surgery, Bellvitge University Hospital, IDIBELL, University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Llop","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Liver Transplantation, Reina Sof\u00eda University Hospital, IMIBIC, University of C\u00f3rdoba, C\u00f3rdoba, Spain."},{"name":"Servicio de Aparato Digestivo, Instituto de Investigaci\u00f3n Puerta de Hierro-Segovia Arana (IDIPHISA), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Pozo-Laderas","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Reina Sofia University Hospital, IMIBIC, C\u00f3rdoba, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Colmenero","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Madrid, Spain."},{"name":"Department of Hepatology and Liver Transplantation, Hospital Cl\u00ednic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Spanish Society of Liver Transplantation and the Spanish Society of Thrombosis and Haemostasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"580.e5","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the united states.","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s12325-020-01307-z","article-title":"Direct oral anticoagulants in patients with liver disease in the era of non-alcoholic fatty liver disease global epidemic: a narrative review.","volume":"37","author":"Ballestri","year":"2020","journal-title":"Adv Ther"},{"key":"R3-20250604","first-page":"CD011557","article-title":"Interventions for preventing thrombosis in solid organ transplant recipients.","volume":"3","author":"Surianarayanan","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research.","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines.","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/hep.31201","article-title":"Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis.","volume":"71","author":"Zermatten","year":"2020","journal-title":"Hepatology"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2019.08.012","article-title":"Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation.","volume":"71","author":"Bhangui","year":"2019","journal-title":"J Hepatol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cld.2020.08.008","article-title":"Cardiac and pulmonary vascular risk stratification in liver transplantation.","volume":"25","author":"Aghaulor","year":"2021","journal-title":"Clin Liver Dis"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000002433","article-title":"International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation.","volume":"103","author":"Tsochatzis","year":"2019","journal-title":"Transplantation"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MOT.0000000000000283","article-title":"Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival.","volume":"21","author":"Malhi","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/heartjnl-2019-315707","article-title":"Recent advances in percutaneous coronary intervention.","volume":"106","author":"Hoole","year":"2020","journal-title":"Heart"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/TP.0000000000001647","article-title":"Outcome of liver transplant recipients with revascularized coronary artery disease: a comparative analysis with and without cardiovascular risk factors.","volume":"101","author":"Satapathy","year":"2017","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/europace\/euz141","article-title":"Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project.","volume":"21","author":"Di Carlo","year":"2019","journal-title":"Europace"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation.","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/jth.15126","article-title":"New anticoagulants: Moving beyond the direct oral anticoagulants.","volume":"19","author":"Fredenburgh","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2018.03.023","article-title":"Oral anticoagulation in patients with liver disease.","volume":"71","author":"Qamar","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/liv.14992","article-title":"Safety of direct oral anticoagulants in patients with advanced liver disease.","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2021.0716","article-title":"Oral antiplatelet therapy after acute coronary syndrome: a review.","volume":"325","author":"Kamran","year":"2021","journal-title":"JAMA"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3390\/jcm10081721","article-title":"Oral antiplatelet therapy for secondary prevention of non-cardioembolic ischemic cerebrovascular events.","volume":"10","author":"De Luca","year":"2021","journal-title":"J Clin Med"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cgh.2010.06.018","article-title":"Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease.","volume":"8","author":"Giannini","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/jth.14598","article-title":"Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural\/surgical bleed risk and patient-specific thromboembolic risk.","volume":"17","author":"Spyropoulos","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cgh.2009.05.004","article-title":"Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study.","volume":"7","author":"De Gottardi","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","article-title":"Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.","volume":"8","author":"Seeff","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"34.e1","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis.","volume":"157","author":"O\u2019Leary","year":"2019","journal-title":"Gastroenterology"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1055\/s-0038-1666861","article-title":"Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th international coagulation in liver disease conference.","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb Haemost"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the american association for the study of liver diseases.","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.","volume":"21","author":"Stine","year":"2015","journal-title":"Liver Transpl"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit.","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.hpb.2015.10.008","article-title":"Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.","volume":"18","author":"Stine","year":"2016","journal-title":"HPB (Oxford)"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/rth2.12253","article-title":"Inherited thrombophilia and portal vein thrombosis in cirrhosis: a systematic review and meta-analysis.","volume":"3","author":"Ma","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2214\/AJR.12.10171","article-title":"Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.","volume":"201","author":"Sandrasegaran","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2214\/ajr.168.3.9057522","article-title":"Benign and malignant portal vein thrombosis: differentiation by CT characteristics.","volume":"168","author":"Tublin","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"480.e1","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis.","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension.","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical Impact and safety of anticoagulants for portal vein thrombosis in cirrhosis.","volume":"114","author":"Pettinari","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MOT.0000000000000506","article-title":"Portal vein thrombosis: yes or no on anticoagulation therapy.","volume":"23","author":"Turon","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0284185115595060","article-title":"Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.","volume":"57","author":"Rosenqvist","year":"2016","journal-title":"Acta Radiol"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/TP.0000000000000729","article-title":"Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis.","volume":"99","author":"Salem","year":"2015","journal-title":"Transplantation"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1714.e2","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort.","volume":"28","author":"Thornburg","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis.","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH08-01-0015","article-title":"Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.","volume":"100","author":"Smalberg","year":"2008","journal-title":"Thromb Haemost"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.avsg.2016.06.029","article-title":"Comparison of systemic thrombolysis versus indirect thrombolysis via the superior mesenteric artery in patients with acute portal vein thrombosis.","volume":"39","author":"Liu","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.27783","article-title":"Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study.","volume":"62","author":"Cerini","year":"2015","journal-title":"Hepatology"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"782","DOI":"10.23736\/S0375-9393.19.13468-2","article-title":"Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE).","volume":"85","author":"Biancofiore","year":"2019","journal-title":"Minerva Anestesiol"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/SLA.0000000000002062","article-title":"Perioperative fresh red blood cell transfusion may negatively affect recipient survival after liver transplantation.","volume":"267","author":"Han","year":"2018","journal-title":"Ann Surg"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jamcollsurg.2012.12.047","article-title":"Blood transfusion requirement during liver transplantation is an important risk factor for mortality.","volume":"216","author":"Rana","year":"2013","journal-title":"J Am Coll Surg"},{"key":"R51-20250604","first-page":"307","article-title":"Red blood cell transfusion policy: a critical literature review.","volume":"15","author":"Franchini","year":"2017","journal-title":"Blood Transfus"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"1178632917691270","DOI":"10.1177\/1178632917691270","article-title":"Perioperative care of patients with liver cirrhosis: a review.","volume":"10","author":"Abbas","year":"2017","journal-title":"Health Serv Insights"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016.","volume":"34","author":"Kozek-Langenecker","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"R54-20250604","first-page":"CD012745","article-title":"Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.","volume":"11","author":"Huber","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2018.11.019","article-title":"Use of prothrombin complex concentrates in patients with decompensated liver cirrhosis is associated with thromboembolic events.","volume":"70","author":"Tischendorf","year":"2019","journal-title":"J Hepatol"},{"issue":"Suppl 6","key":"R56-20250604","first-page":"S61","article-title":"Viscoelastic testing in liver transplantation.","volume":"60","author":"Sakai","year":"2020","journal-title":"Transfusion"},{"key":"R57-20250604","first-page":"29","article-title":"Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.","volume":"91","author":"Dalmau","year":"2000","journal-title":"Anesth Analg"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-6143.2006.01591.x","article-title":"Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis.","volume":"7","author":"Molenaar","year":"2007","journal-title":"Am J Transplant"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2007.10.003","article-title":"Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design.","volume":"155","author":"Myles","year":"2008","journal-title":"Am Heart J"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jth.12078","article-title":"The incidence and magnitude of fibrinolytic activation in trauma patients.","volume":"11","author":"Raza","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MBC.0b013e32835975ed","article-title":"The coagulopathy of liver disease: does vitamin K help?","volume":"24","author":"Saja","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/phar.1827","article-title":"Comparison of fresh-frozen plasma, four-factor prothrombin complex concentrates, and recombinant factor viia to facilitate procedures in critically ill patients with coagulopathy from liver disease: a Retrospective Cohort Study.","volume":"36","author":"Kwon","year":"2016","journal-title":"Pharmacotherapy"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.25475","article-title":"Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum.","volume":"94","author":"Cuker","year":"2019","journal-title":"Am J Hematol"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-0042-102652","article-title":"Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.","volume":"48","author":"Veitch","year":"2016","journal-title":"Endoscopy"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.redar.2018.07.003","article-title":"Recommendations for perioperative antiplatelet treatment in non-cardiac surgery. Working Group of the Spanish Society of Anaesthesiology-Resuscitation and Pain Therapy, Division of Haemostasis, Transfusion Medicine, and Perioperative Fluid Therapy. Update of the Clinical practice guide 2018.","volume":"66","author":"Sierra","year":"2019","journal-title":"Rev Esp Anestesiol Reanim (Engl Ed)"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"916","DOI":"10.5604\/01.3001.0010.5283","article-title":"Rotational thromboelastometry or conventional coagulation tests in liver transplantation: comparing blood loss, transfusions, and cost.","volume":"16","author":"Smart","year":"2017","journal-title":"Ann Hepatol"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"583","DOI":"10.5500\/wjt.v6.i3.583","article-title":"Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation.","volume":"6","author":"De Pietri","year":"2016","journal-title":"World J Transplant"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5500\/wjt.v5.i4.165","article-title":"Reducing transfusion requirements in liver transplantation.","volume":"5","author":"Donohue","year":"2015","journal-title":"World J Transplant"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4097\/kja.19169","article-title":"The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management.","volume":"72","author":"G\u00f6rlinger","year":"2019","journal-title":"Korean J Anesthesiol"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.23494","article-title":"Use of higher thromboelastogram transfusion values is not associated with greater blood loss in liver transplant surgery.","volume":"18","author":"Wang","year":"2012","journal-title":"Liver Transpl"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/TP.0000000000002092","article-title":"Perioperative coagulation management in liver transplant recipients.","volume":"102","author":"Bezinover","year":"2018","journal-title":"Transplantation"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jamcollsurg.2008.12.032","article-title":"Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients.","volume":"208","author":"Duffy","year":"2009","journal-title":"J Am Coll Surg"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jlts.2001.22040","article-title":"Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes.","volume":"7","author":"Pastacaldi","year":"2001","journal-title":"Liver Transpl"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ajt.12543","article-title":"De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.","volume":"14","author":"Asrani","year":"2014","journal-title":"Am J Transplant"},{"issue":"Suppl 3","key":"R77-20250604","article-title":"Perioperative management of the bleeding patient.","volume":"117","author":"Ghadimi","year":"2016","journal-title":"Br J Anaesth"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/TP.0000000000000785","article-title":"Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted Patients.","volume":"100","author":"Ghabril","year":"2016","journal-title":"Transplantation"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/lt.23874","article-title":"Etiology and management of hepatic artery thrombosis after adult liver transplantation.","volume":"20","author":"Mourad","year":"2014","journal-title":"Liver Transpl"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.sopen.2019.12.004","article-title":"Perioperative thrombelastography serves as an important assessment tool of transfusion requirements during liver transplantation.","volume":"2","author":"Graff","year":"2020","journal-title":"Surg Open Sci"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.recesp.2018.01.001","article-title":"Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.","volume":"71","author":"Vivas","year":"2018","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.3748\/wjg.v24.i27.2931","article-title":"Perioperative thromboprophylaxis in liver transplant patients.","volume":"24","author":"De Pietri","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R84-20250604","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"R85-20250604","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1160\/TH07-10-0611","article-title":"Clinical presentation and time-course of postoperative venous thromboembolism: results from the RIETE Registry.","volume":"99","author":"Arcelus","year":"2008","journal-title":"Thromb Haemost"},{"key":"R86-20250604","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jvs.2012.12.073","article-title":"Prediction of postdischarge venous thromboembolism using a risk assessment model.","volume":"58","author":"Iannuzzi","year":"2013","journal-title":"J Vasc Surg"},{"key":"R87-20250604","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.3748\/wjg.v12.i48.7725","article-title":"New insights into the coagulopathy of liver disease and liver transplantation.","volume":"12","author":"Senzolo","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3748\/wjg.v26.i21.2691","article-title":"Tailored classification of portal vein thrombosis for liver transplantation: focus on strategies for portal vein inflow reconstruction.","volume":"26","author":"Teng","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.surg.2020.07.023","article-title":"Liver transplantation in patients with portal vein thrombosis: A strategic road map throughout management.","volume":"168","author":"Sharshar","year":"2020","journal-title":"Surgery"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/jth.15364","article-title":"Treatment of bleeding in patients with liver disease.","volume":"19","author":"Northup","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R91-20250604","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease.","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R92-20250604","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1067\/j.cpsurg.2016.06.006","article-title":"Management of gastrointestinal bleeding in patients with cirrhosis.","volume":"53","author":"Ertel","year":"2016","journal-title":"Curr Probl Surg"},{"key":"R93-20250604","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-0035-1550430","article-title":"Rebalanced hemostasis in patients with acute liver failure.","volume":"41","author":"Lisman","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force.","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11239-015-1310-7","article-title":"Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment.","volume":"41","author":"Burnett","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMra1206531","article-title":"Management of antithrombotic therapy in patients undergoing invasive procedures.","volume":"368","author":"Baron","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:09:39Z","timestamp":1749049779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004014","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}